+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Tourism Market by Treatment Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • ID: 4828458
  • Report
  • Region: Global
  • 157 pages
  • Allied Analytics LLP
1 of 4
Medical Tourism Market Overview:

The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.

Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers’ home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, cardiovascular treatment, and others.

The report segments the market into treatment type and region. Based on treatment type, the market is segmented into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and other treatments. Based on region, the medical tourism market is studied across North America (U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Indonesia, Singapore, Malaysia, Thailand, South Korea, Taiwan, and, rest of Asia-Pacific), and LAMEA (Brazil, Venezuela, Costa Rica, UAE, South Africa, and rest of LAMEA).

Key Benefits for Medical Tourism Market:

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

Medical Tourism Key Market Segments:

By Treatment Type

Dental Treatment
Cosmetic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Cardiovascular Treatment
Orthopedic Treatment
Neurological Treatment
Cancer Treatment
Fertility Treatment
Other Treatments

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
India
China
Indonesia
Singapore
Malaysia
Thailand
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Venezuela
Costa Rica
UAE
South Africa
Rest of LAMEA

List Of Key Players Profiled in the Report

Apollo Hospitals Enterprise Limited
Fortis Healthcare Limited
Asian Heart Institute
KPJ Healthcare Berhad
NTT Medical Center Tokyo
Seoul National University Hospital
UZ Leuven
Wooridul Spine Hospital
Aditya Birla Memorial Hospital
Barbados Fertility Center
Prince Court Medical Centre
Samitivej PCL.

List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)

Bumrungrad International Hospital
Min-Sheng General Hospital
Raffles Medical Group
Bangkok Hospital Medical Center
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies
3.4. Reimbursement scenario
3.4.1. Developed regions
3.4.2. Developing regions
3.5. Government regulations
3.6. Top player positioning, 2017
3.7. Porters five forces analysis
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Affordable good quality care
3.8.1.2. Availability of quality care
3.8.1.3. Accessible information and care
3.8.1.4. Assistance and support from government agencies and associations
3.8.2. Restraints
3.8.2.1. Limited coverage and lengthy partial reimbursement by payers
3.8.2.2. Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues
3.8.3. Opportunities
3.8.3.1. Overseas promotional offices is a key source of medical tourists
3.8.3.2. Wider hospital network under insurance coverage for cashless transactions
3.8.4. Impact analyses

CHAPTER 4: MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Dental Treatment
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.3. Cosmetic Treatment
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.4. Cardiovascular treatment
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.5. Orthopedic treatment
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.6. Neurological treatment
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.7. Cancer treatment
4.7.1. Key market trends, growth factors, and opportunities
4.7.2. Market size and forecast, by region
4.8. Fertility treatment
4.8.1. Key market trends, growth factors, and opportunities
4.8.2 Market size and forecast, by region
4.9. Other treatments
4.9.1. Key market trends, growth factors, and opportunities
4.9.2. Market size and forecast, by region

CHAPTER 5: MEDICAL TOURISM MARKET, BY REGION
5.1. Overview
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by country
5.2.3. Market size and forecast, by treatment type
5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast
5.3. Europe
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by country
5.3.3. Market size and forecast, by treatment type
5.3.3.1. UK market size and forecast
5.3.3.2. Germany market size and forecast
5.3.3.3. France market size and forecast
5.3.3.4. Italy market size and forecast
5.3.3.5. Spain market size and forecast
5.3.3.6. Rest of Europe market size and forecast
5.4. Asia-Pacific
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by country
5.4.3. Market size and forecast, by treatment type
5.4.3.1. India market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. Indonesia market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. South Korea market size and forecast
5.4.3.8. Taiwan market size and forecast
5.4.3.9. Rest of Europe market size and forecast
5.5. LAMEA
5.5.1. Key market trends, growth factors, and opportunities
5.5.2. Market size and forecast, by country
5.5.3. Market size and forecast, by treatment type
5.5.3.1. Brazil market size and forecast
5.5.3.2. Venezuela market size and forecast
5.5.3.3. Costa Rica market size and forecast
5.5.3.4. UAE market size and forecast
5.5.3.5. South Africa market size and forecast
5.5.3.6. Rest of Europe market size and forecast

CHAPTER 6: COMPANY PROFILES
6.1. Apollo Hospitals Enterprise Limited
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments
6.2. FORTIS HEALTHCARE LIMITED
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.3. Asian Heart Institute
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Product portfolio
6.4. Kpj Healthcare Berhad
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Product portfolio
6.4.5. Business performance
6.4.6. Key strategic moves and developments
6.5. NTT Medical Center Tokyo
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.6. SEOUL NATIONAL UNIVERSITY HOSPITAL.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments
6.6.4. Product portfolio
6.7. UZ Leuven
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.8. Wooridul Spine Hospital
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Product Portfolio
6.9. Aditya Birla Memorial Hospital
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.10. Barbados Fertility Center
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Operating business segments
6.10.4. Product portfolio
6.11. Prince Court Medical Centre
6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments
6.11.4. Product portfolio
6.12. Samitivej PCL.
6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio

*Full List of Tables and Figures Available on Enquiry.

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to this report titled, 'Medical Tourism Market by Treatment Type: Global Opportunity Analysis and Industry Forecast, 2018 - 2025' the market was valued at $53,768 million in 2017, and is projected to reach $143,461 million by 2025, growing at a CAGR of 12.9% from 2018 to 2025.

The process of traveling outside the country of residence to avail medical treatment and care is known as medical tourism. Medical tourists avail different treatments such as cancer treatment, cardiovascular treatment, neurological treatment, fertility treatment, and others. The escalation in healthcare costs associated in developed countries, has forced individuals to look for affordable alternatives. This boosts the growth of the medical tourism market.

Affordability, availability, and accessibility of good quality healthcare services coupled with support and assistance from tourism departments & local governments fuel the market growth. In addition, increase in incidence of cancer and other serious ailments is anticipated to drive the demand for healthcare services, which in turn is expected to boost the growth of the medical tourism market. Limited coverage and lengthy partial reimbursement offered by insurance companies along with difficulties associated with cross border travel, such as language barriers, connectivity, documentation, and VISA approval issues, are projected to impede market growth. Conversely, wider hospital network under insurance coverage for cashless transactions serve as an opportunity for the growth of the medical tourism market.

Based on treatment type, the cancer treatment segment accounted for the highest market share in 2017 due to surge in incidence of cancer worldwide. This is projected to increase the number of cross-border travelers seeking good quality cancer treatment. In addition, cancer treatment is an expensive and prolonged treatment, hence reduced cost of treatment in different countries fuels the growth of the market. Furthermore, due to lack of availability of advanced treatment in some countries, patients choose to travel to other countries that offer advanced healthcare facilities.

Key Findings of the Medical Tourism Market:

North America occupied nearly one-third share of the global medical tourism market in 2017.
The cancer treatment segment is anticipated to grow with the highest CAGR throughout the forecast period.
The cosmetic treatment segment accounted for around two-fifths share of the market in 2017.
Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

North America accounted for the highest market share due recent joint commission international (JCI) accreditations to hospitals (JCI accreditation is considered the gold standard in global health care), which makes them a preferred choice for medical tourists. In addition, advanced specialized treatments for cancer, neurological, and cardiovascular ailments also serves as a growth factor for the medical tourism market in North America. Asia-Pacific possesses the highest market potential due to the availability of good quality care at a cost less than 70% of the cost of services in North America. In addition, significant investments by government to improve healthcare infrastructure also contributes toward the growth of this market.

The report provides an extensive competitive analysis and profiles of the key market players such as Apollo Hospitals Enterprise Limited; Fortis Healthcare Limited; Asian Heart Institute; KPJ Healthcare Berhad; NTT Medical Center Tokyo; Seoul National University Hospital, UZ Leuven, Wooridul Spine Hospital, Aditya Birla Memorial Hospital, Barbados Fertility Center, Prince Court Medical Centre, and Samitivej PCL.
Note: Product cover images may vary from those shown
5 of 4

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll